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Background: Neonatal sepsis is a major cause of morbidity and mortality in low-income
settings. As signs of sepsis are non-specific and deterioration precipitous, antibiotics are
often used profusely in these settings where diagnostics may not be readily available.
Harare Central Hospital, Zimbabwe, delivers 12000 babies per annum admittingw4800 to
the neonatal unit. Overcrowding, understaffing and rapid staff turnover are consistent
problems. Suspected sepsis is highly prevalent, and antibiotics widely used. We audited
the impact of training and benchmarking intervention on rationalizing antibiotic pre-
scription using local, World Health Organization-derived, guidelines as the standard.
Methods: An initial audit of admission diagnosis and antibiotic use was performed
between 8th May - 6th June 2018 as per the audit cycle. An intern training programme,
focusing on antimicrobial stewardship and differentiating between babies ‘at risk of’
versus ‘with’ clinically-suspected sepsis was instituted post-primary audit. Re-audit was
conducted after 5 months.
Results: Sepsis was the most common admitting diagnosis by interns at both time points
but reduced at repeat audit (81% versus 59%, P<0.0001). Re-audit after 5 months dem-
onstrated a decrease in antibiotic prescribing at admission and discharge. Babies pre-
scribed antibiotics at admission decreased from 449 (98%) to 96 (51%), P<0.0001. Inpatient
days of therapy (DOT) reduced from 1243 to 1110/1000 patient-days. Oral amoxicillin
prescription at discharge reduced from 349/354 (99%) to 1% 1/161 (P<0.0001).ment of Paediatrics & Child Health, UZCHS Parirenyatwa Hospital Complex, Mazowe Street, Harare,
(G. Chimhini).
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ivecommons.org/licenses/by-nc-nd/4.0/).
G. Chimhini et al. / Infection Prevention in Practice 2 (2020) 1000462Conclusion: A substantial decrease in antibiotic use was achieved by performance feed-
back, training and leadership, although ongoing performance review will be key to
ensuring safety and sustainability.
ª 2020 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
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The World Health Organization (WHO) estimates that
infection causes w25% of 2.8 million annual neonatal deaths
alongside lasting morbidity [1]. Neonatal hospital-acquired
infection (HAI) is a major cause of mortality with rates in
low/middle-income countries (LMICs) w3e20 times higher
than elsewhere [2]. Risks include overcrowding, poor infection
control practices and reuse of single-use equipment [2]. The
risk and severity of sepsis mean neonatal units are liable to
overuse antibiotics. Clinicians face a difficult choice of bal-
ancing the serious risk of sepsis in this vulnerable population
with the medium-long term risk of adverse effects associated
with antimicrobial use, which include late-onset sepsis,
necrotising enterocolitis and gut dysbiosis [3,4]. Additionally,
at a population level, excessive antimicrobial use drives
resistance. In Malawi, a review of blood culture isolates over
nineteen years (1998e2017) showed an increase in resistance
to all first-line antimicrobials from 7% to 68% in babies<60 days
old [5]. This is especially worrying in LMICs where second- and
third-line antimicrobials may be inaccessible.
Neonatal sepsis is challenging to diagnose particularly where
laboratory diagnostics are lacking. Clinical features of neonatal
sepsis are non-specific and clinical diagnostic algorithms such as
the WHO-recommended Integrated Management of Childhood
and Neonatal Illness (IMNCI) [6] algorithm maximises sensitivity
over specificity. Antimicrobial stewardship programs are crucial,
but often neglected, intervention for neonatal units in LMICs
with limited access to second/third line antimicrobials. The
optimal antimicrobial stewardship approach for neonates in
LMICs is uncertain-a balance must be struck between prompt
administration of antibiotics to prevent sepsis-related mortality
on one hand, with minimizing individual side effects and pre-
serving population-level therapeutic efficacy (i.e. reducing
unnecessary usage) on the other. Simple tools such as audit,
training and benchmarking may be useful in safely rationalising
antibiotic prescription without excessive cost.
Local problem
Harare Central Hospital (HCH), a public sector hospital in
Zimbabwe, delivers 12000 babies per year. The 100-cot neo-
natal unit runs at 100e140% capacity and accepts nationwide
surgical referrals. Overcrowding and understaffing are constant
issues, as is the rapid turnover of staff, in particular, medical
interns who frequently have minimal prior neonatal experi-
ence. Sepsis is a frequent admitting diagnosis, and there is a
high level of concern about HAIs (a recent Klebsiella outbreak
had a 30% case fatality rate), in combination with a slow turn-
around time for blood culture results. Although there were
hard copy guidelines for first/second-line antibiotics on the
ward, these were often not used. There was no formal anti-
microbial stewardship programme prior to this audit.Microbiology facilities for processing blood cultures are onsite
in a different building. Blood cultures are processed manually
using locally manufactured media, with limited isolate identi-
fication/susceptibility testing depending on consumable
availability. Results are retrieved from the laboratory daily by
intern doctors but delays are frequent. We believed antibiotic
prescription rates were likely to be high and duration pro-
longed. In the context of severe resource constraints, any
quality improvement approaches should be simple and inex-
pensive, utilising existing resources where possible.
We aimed to audit antibiotic use and admission diagnoses
before and after performance feedback and training inter-
ventions at HCH neonatal unit.
Methods
A simple audit cycle was planned with feedback, education
and training by senior staff as the main intervention. The
standards used were local guidelines based on WHO IMNCI
guidelines [6] for management of suspected sepsis and inclu-
ded risk factors and symptoms (Supplementary Table 1). First-
line antibiotics for suspected sepsis were intravenous ampi-
cillin or benzylpenicillin plus gentamicin. There was no indi-
cation within local guidelines for oral amoxicillin at any point.
Measurement
Baseline assessment consisted of a prospective audit of all
admissions to the neonatal unit between 8th May-6th June 2018
[7]. There were no specific exclusion criteria. Admitting diag-
noses (as documented by the admitting intern), vital signs,
examination and investigation findings and type and duration
of antimicrobial therapy were recorded. Babies could have
multiple diagnoses e.g. prematurity and respiratory distress.
Timing of microbiological investigations carried out (e.g. pre/
post antibiotics), results and time to receipt of positive results
were documented. For longer admissions, recurrent episodes
of suspected sepsis and antibiotic use were documented. Par-
ticipants were followed to the earliest of death, discharge, or
loss to follow up. A single researcher collected anonymised
data from contemporaneous clinical records using REDCap
(Vanderbilt University, version 4.0.2) [8]. These data were
collected as a baseline assessment prior to a large-scale quality
improvement study, introducing an Android application (Neo-
Tree [9]) as a digital quality improvement system. The anti-
microbial prescription rates were so high that the interventions
described below were instigated prior to NeoTree
commencement.
Intervention
Audit results were fed back to unit staff and hospital
executive (August 2018) after which training/education
Table 1
Characteristics and outcome of 650 babies admitted to Harare Central Hospital at initial and repeat audit
Initial audit Repeat audit P*
Number of patients (unless
otherwise specified)




Female 225 49 79 42 0.10
Birth weight in kg 2.8 2e3.4 2.9 2.3e3.25 1.00
Inborn 369 80 153 80 1.00
Caesarean section 115 25 48 25 1.00
Most common diagnoses at admission by interns
Hypoxic ischaemic
encephalopathy
71 15 42 22 0.05
Meconium exposure/
aspiration
95 21 28 15 0.08
Prematurity (<37 weeks) 133 29 56 29 0.92
Respiratory distress 207 45 90 47 0.60
Sepsis 371 81 111 59 <0.0001
Known maternal HIV
infection
60 13 26 14 0.90
Outcomes
Discharged home 361 79 161 84 0.08
Died 95 20 26 14 0.05
Transferred to another
hospital
2 0.4 0 0 1.00
Unknown 1 0.2 2 1 0.20
Duration of admission in
days (median)
3 2.0e6.0 2 1.0e4.3 <0.0001
* Fisher’s Exact Test, t-test or Wilcoxon rank-sum test.
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considered in intervention design were the inexperience of
interns in managing neonates rendering training/education key
implementation tools and the potential for utilizing existing
unit meetings to disseminate learning. Additionally, babies
were admitted by intern doctors and reviewed by a senior
paediatrician the following day, allowing rapid feedback on
adherence to guidelines.
Subsequent training over three months for interns and
nurses occurred. Firstly, a unit induction session by consultants
for interns on antimicrobial guidelines for neonates was
introduced. This was consolidated at weekly unit meetings of
nursing and medical staff, disseminating key messages from the
preliminary audit such as discontinuing the empiric pre-
scription of ‘prophylactic’ oral amoxicillin on admission for
babies not on intravenous antibiotics and at discharge. Neo-
natal sepsis guidelines for first-line and second-line antibiotics
were displayed on the unit. Finally, antimicrobial stewardship
consultant-led ward-rounds were introduced, which reinforced
differentiating between babies ‘at risk of’ versus ‘with’
clinically-suspected sepsis, such that asymptomatic babies
with one risk factor for sepsis were to be admitted for obser-
vation of vital signs for 24 hours before starting antibiotics.
Over the course of the three months, discussions during ward
meetings included clarification of criteria for starting patients
on antibiotics, frequency of observation over 24 hours, dis-
continuation of antibiotics with negative blood culture results
and antimicrobial use for cases with recurring episodes of
sepsis or surgical patients transferred in from district neonatal
units. Features important for the success of the interventionwere clear messaging and committed leadership from the
neonatal consultants and senior nursing staff, combined with
the utilization of existing platforms such as the weekly unit
meeting and regular teaching ward rounds. There was also
nursing capacity and expertise to safely observe untreated
babies with one risk factor.
Intervention impact
A repeat retrospective audit specifically reviewing anti-
microbial prescriptions was conducted from 29th October to
11th November 2018 as above. REDCap data dictionaries for
initial/repeat audit are included in Supplementary Material. A
sample size of 138 would be needed at each audit to detect a
decrease in prescription rates from 95% to 85% with 80% power
(two-sided alpha¼0.05). Other than the training as described
above, no other interventions or changes to practice were
instigated between audits, meaning observed outcomes were
likely due to the training. Unfortunately, laboratory resource
constraints meant that at repeat audit, culture results were
not consistently available.
Analysis
Data were analysed in R Studio (Version 3.3.3) [10]. Char-
acteristics between audits were compared using chi-squared
tests and t-tests for categorical and continuous variables
respectively. Inpatient and total days of therapy were calcu-
lated to assess antibiotic exposure [11]. The manuscript was
prepared using the SQUIRE template [12].
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Intervention delivery
This audit cycle took place over six months from baseline
assessment to repeat audit, with three months dedicated to
the delivery of the training/feedback intervention. The major
modification overtime was the move from the formal
consultant-led induction training to less formal peer-peer
training, but as regular consultant feedback during ward
rounds and the weekly unit meetings continued, messaging
remained consistent. A further evolution was the shift to ret-
rospective data collection over a shorter timeframe for the
repeat audit. This was partly due to earlier than the planned
introduction of the NeoTree application, and partly due to staff
shortages secondary to nationwide industrial action.Process measures and outcomes
There were 648 babies included, 459 in the primary and 189
in the repeat audit (Table 1).
Birth weight, gestational age and the rest of demographics
and clinical features were similar in the primary and repeat
audit. Sepsis was the most common admitting diagnosis by
interns at both timepoints but reduced at repeat audit (81%
versus 59%, P<0.0001).
Antibiotic prescription on admission reduced significantly:
449 (98%) versus 96 (51%) respectively, P<0.0001. The most
common antibiotics at admission for both timepoints were
benzylpenicillin and gentamicin, prescribed to 65% and 67%
respectively at primary audit and decreasing to 51% each at re-
audit (P<0.0001 for both, Supplementary Table 2). Prescription
of oral amoxicillin at admission reduced from 22% to 0%, the
largest decrease across all antimicrobials. There was also less
divergence from recommended first-line therapy: babies pre-
scribed ceftriaxone at first admission decreasing from 9% to
1.5% (P¼0.0004). Antimicrobial prescription for admissions that
were not sepsis-related, such as macrosomia and safekeeping,
decreased from 23/24 (96%) to 1/10 (10%) and 14/14 (100%) to
0/4 (0%) respectively.
Inpatient days of therapy (DOT) reduced from 1243 to 1110/
1000 patient-days and the median duration of therapy reduced
from 6 days (IQR 5e9) to 3 days (IQR 2e5, P<0.0001) when
antibiotics were given (Supplementary Table 3). Prescription of
seven days of amoxicillin at discharge reduced from 349/354
(99%) to 1/161 (1%, P<0.0001). There was no evidence that
these reductions increased mortality, which occurred in 20%
versus 14% of admitted babies across the two audits respec-
tively (P¼0.05). Data on antimicrobial prescription at admis-
sion were available for all babies. Outcome data including DOT
were missing for three babies (1/459 (0.2%) at initial and 2/189
(1%) at repeat audit respectively, P¼0.20).In the primary audit, blood cultures were taken for 44%
(196/445) of those starting antibiotics on admission, of which
65/196 (33%) received results (median time-to-result 6 days,
IQR 5e9) (Supplementary Results, Supplementary Table 4).
Only 7/196 (4%) cultures sent arrived in time to impact on
therapy. There were 75 episodes of subsequent sepsis in 54
(12%) admitted babies with 7/36 (20%) positive cultures leading
to treatment modification. Klebsiella pneumoniae/Lactose-
fermenting coliforms were common pathogens even at admis-
sion, all but one of which was resistant to third-generation
cephalosporins (Supplementary Figure 1). Minimal culture
data were available at repeat audit owing to resource
constraints.Discussion
In summary, sepsis was the most common admitting diag-
nosis on the neonatal unit and antibiotic use was high even in
the absence of sepsis. Antimicrobial usage was reduced by an
inexpensive training intervention.
Overall days of antibiotic therapy were higher at both time
points than reported data from Chinese neonatal units (380
DOT/1000 patient-days) [11] but lower than Russia (1426 DOT/
1000 patient-days) [13]. In general, data on DOT from African
neonatal units are lacking, an evidence gap that is important to
fill to allow inter-unit comparison and benchmarking to ensure
that antimicrobial stewardship interventions are implemented
safely and effectively. In high-income settings, reduced anti-
biotic usage secondary to effective stewardship has safely
reduced consumption without adversely impacting mortality
despite neonatal vulnerability to sepsis [3,14]. Timely blood
culture feedback has also been shown to reduce the duration of
therapy [15]. Although our unit has microbiological diagnostics
onsite (unusual for LMICs), it is still vulnerable to laboratory
supply and staffing shortages as experienced by other units
[16]. Only 44% of babies commenced on antibiotics for sus-
pected sepsis in the preliminary audit had a blood culture
taken, and feedback of results was too slow for clinical rele-
vance, meaning asymptomatic babies may have continued
antibiotics longer than necessary.
Although our data must be interpreted cautiously due to
some differences between the initial and repeat audit meth-
odology, we observed a marked reduction in antimicrobial
prescribing on our neonatal unit with simple, inexpensive
methods of training, feedback and focusing on stewardship
during ward-rounds. Initially, there was a prolific prescription
of antimicrobials, both for babies with risk factors and/or
clinical signs of sepsis, but also for diagnoses that would not
usually merit antimicrobial treatment. In our unit differ-
entiating babies with signs of sepsis who merited treatment,
and those asymptomatic babies with only one risk factor who
could be admitted for observation was a major feature in the
training for interns and was also reinforced during ward-
rounds, which may have impacted on the rate of doc-
umentation of ‘sepsis’ at admission. Another feature of train-
ing emphasized that there was minimal evidence for
‘prophylactic’ or empiric antibiotics (amoxicillin) at discharge
for neonates admitted to the unit.
Finally, perhaps the most effective part of the audit was the
process of feedback alone. We are continuing to benchmark
our progress monthly, a process that has been used to good
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are monitoring antibiotic prescription in babies who should be
getting antibiotics to ensure we were not being overly con-
servative, withholding this crucial therapy inappropriately.
Attaining a safe balance to ensure babies who needed anti-
biotics receive them promptly while protecting those who do
not will be a challenging ongoing process.
Limitations
The limitations in this audit cycle were the prospective
versus retrospective methods used in the first and second audit
respectively, and the smaller sample size in the re-audit. The
retrospective re-audit was used specifically to review anti-
microbial use on the unit prior to a large-scale quality
improvement project due to be initiated in the unit (use of
NeoTree, a tablet-based digital quality improvement system
with decision support [9]). It was limited to retrospective as
opposed to prospective data collection due to staff shortages
secondary to industrial action. Consequently, the borderline
differences in mortality and admission duration between
groups should be interpreted with caution. However, the dif-
ferences in antimicrobial prescription rates pre/post-
intervention are substantial (99%e1%, P<0.0001), and
unlikely to be explained by the difference in methods alone.
Finally, we do not have follow-up data post-discharge so are
unable to assess medium/long-term mortality.
In terms of generalizability, our context of having a doctor-
led service with frequent consultant presence on the ward to
reinforce training may not be replicable in other LMIC settings.
We also had nursing and spatial capacity to admit babies for
observation if they had only one risk factor. However, the fact
that this audit was conducted over a relatively short period, in
challenging circumstances and with no additional funding for
the training and education intervention, may encourage others
in low-income, high-pressure settings and provide a bench-
mark, as well as demonstrating that simple interventions can
still be effective.
Conclusion
We achieved a substantial decrease in antibiotic use with
inexpensive interventions. For a low-resource hospital, the
potential cost savings are also important and merit further
assessment. High antibiotic use can be reduced by perform-
ance feedback, training and leadership although ongoing per-
formance review will be key to ensuring safety and
sustainability.
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